China Cord Blood Corporation (CO) Reports In-Line Q4 EPS, Revenues Top Expectations
Tweet
Share
E-mailGet Alerts CO Hot Sheet
Join SI Premium – FREE
China Cord Blood Corporation (NYSE: CO) reported Q4 EPS of $0.05, in-line with the analyst estimate of $0.05. Revenue for the quarter came in at $14.5 million versus the consensus estimate of $13.49 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
- Kyverna Therapeutics, Inc. (KYTX) Tops Q2 EPS by 45c
- Transact Technologies (TACT) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
